Titan Pharmaceuticals, Inc. (de) (TTNP) saw downtrend of -3.76% in the recent trading with $4.61 being its most recent. The current price level -19.97% lower than the highest price of $5.76 marked by the stock while trading over the past 52-weeks, whereas it is 52.15% higher than the lowest price of $3.03 the company dropped to over past 52-weeks. The latest news story on TTNP appeared in (Associated Press Finance) under the title “Titan Pharmaceuticals: Q2 Earnings Snapshot”.
Squeezing the time span to 30 day period shows us the stock is currently trading -3.96% below one month high and is +28.95% above of the lowest during that time. Looking into the simple moving average, Titan Pharmaceuticals, Inc. (de) (TTNP)’s stock stands at a SMA-50 of $4.38 while that of 5-day is reading $4.37.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and TTNP’s SMA-200 as of now is $4.05.
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform.
Titan Pharmaceuticals, Inc. (de) Earnings – What Happened With TTNP
Coming around sales and income figures on TTNP Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
TTNP – Titan Pharmaceuticals, Inc. (de) Stock Earnings Estimates
The perspective of Titan Pharmaceuticals, Inc. (de) (NASDAQ:TTNP)’s current quarter earnings identifies that analysts are in consensus over the estimate of -4.2 for stock’s EPS in the current quarter. Company’s EPS for the last quarter was -3.6.
Titan Pharmaceuticals, Inc. (de) – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 1.33 million. TTNP does have institutional investors; and they hold 2.83% of the stock.
As on 2024-06-30, TRUIST FINANCIAL CORP was the top most holder in Titan Pharmaceuticals, Inc. (de) (NASDAQ:TTNP) with an ownership of 31255.0 shares of the company or 3.4196 of the stake worth $0.17 million. The filing also reveals TOWER RESEARCH CAPITAL LLC (TRC) as the second largest holder in the company with a control over 0.0784 of the outstanding shares. Its stake is worth $3994.0 for having 717.0 shares in hand.
MCF ADVISORS LLC also came holding a key position in the company during the recent quarter and it now holds 0.0181 of the outstanding shares. With this there are now 21.0 institutions which have possession in TTNP’s shares.
Key Metrics for TTNP
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Titan Pharmaceuticals, Inc. (de) has a debt to equity ratio of 0.00.
Technical Analysis of Titan Pharmaceuticals, Inc. (de) (NASDAQ:TTNP) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Titan Pharmaceuticals, Inc. (de) (TTNP), we notice that the stock’s 20-day average volume is at 180,005 shares. Medium term indicators at an average of 50% are spotting the stock at Buy with its 50-day average volume of 124,366 shares. And to end, TTNP’s 100-day average volume is 82,043 shares with 100% of the long-term indicators pointing towards Buy for the stock.
